Učitavanje...
CTD与PCD方案治疗新诊断多发性骨髓瘤患者的疗效、预后及安全性分析
OBJECTIVE: To observe the efficacy and safety of CTD (cyclophosphamide, thalidomide, dexamethasone) and PCD (bortezomib, cyclophosphamide, dexamethasone) regimens in treatment of patients with newly diagnosed multiple myeloma (NDMM). METHODS: A retrospective analysis was carried out on 88 cases of N...
Spremljeno u:
| Izdano u: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Editorial office of Chinese Journal of Hematology
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342733/ https://ncbi.nlm.nih.gov/pubmed/28468087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.04.004 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|